Medical Education Grant Process

Clinical Areas of Interest

Pfizer is currently accepting grant applications for independent education in the following areas:

Cardiovascular Metabolic

• Cardiovascular Risk/Diabetes
• Thrombosis

Endocrinology

• Growth Disorders

Healthcare Quality and Leadership

• Patient Safety
• Adherence
• Health Disparities

Infectious Disease

• Bacterial
• Fungal
• HIV/AIDS

Neuroscience, Pain and Inflammation

• Dementia
• Psychosis
• Multiple Sclerosis
• Epilepsy
• Diabetic Neuropathy
• Fibromyalgia
• Neuropathic Pain
• Nociceptive Pain/Arthritis
• Acute/Chronic Post-operative Pain
• Generalized Anxiety Disorder
• Restless Leg Syndrome

Oncology

• Breast
• Lung
• Gastrointestinal (GIST, Colorectal, HCC, Pancreatic)
• Cardiovascular Impact of Cancer Therapy

Ophthalmology

• Glaucoma

Respiratory

• Pulmonary Arterial Hypertension
• Smoking Cessation
• Chronic Obstructive Pulmonary Disease (COPD)

Urology

• Overactive Bladder

View Pfizer's educational goal statements for each of these clinical areas.

Organizations Eligible to Receive Grants and Process Overview

Pfizer is committed to supporting CME and independent education initiatives that are most likely to improve patient health, and believe that the likelihood of improving patient health increases when education is integrated with quality.

We believe commercial support should be aligned with the literature on effective continuing education for health professionals, and the highest level of standards endorsed by the medical community such as those found in the 2006 ACCME criteria.

Patients are best served when commercial support is provided to those organizations that are engaged in patient care or represent those who deliver patient care. These organizations are in the best position to achieve the highest recognized standards of quality in the medical profession today.

We continue to support proposals that include services from other stakeholder groups as we believe many of these organizations provide a valuable and often essential supportive role that is valued by the medical profession.

Types of organizations eligible to apply for grants include hospitals, academic medical centers, schools of nursing or pharmacy, professional societies and associations.

Please note that organizations must first register on the grant submission site. Only applicants who have been informed of approval of their registration are able to submit grant requests.

View the full description of the grant application process.

Policies

Throughout the year the Medical Education Group may send out communications directly to registered users of the Pfizer Grant Management System (GMS) with regard to important and time-sensitive topics (e.g., change in policy, changes in process or procedures, system enhancements). Such communications are posted below for your reference in descending chronological order.

In addition to announcements prepared by the Medical Education Group, posted below you will find other reference materials such as our response to the ACCME in September regarding the June 2008 Policy Announcement and Request for Comments.

Date Posted	Description	Link
11/04/09	Pfizer's support of ACCME Transparency Statement
10/20/09	Pfizer Medical Education Group – integration
02/03/09	Change in policy regarding direct funding by Pfizer Medical Education Group to non-U.S. based organizations
12/03/08	Change in Pfizer's CME Grant Policy pursuant to state Attorneys General settlement-CME faculty with promotional speaking involvement
9/15/08	Pfizer's response to ACCME Call for Comments
8/27/08	NEW quarterly competitive grant review process
7/18/08	Statement on Pfizer's recent policy change re CME support
7/18/08	FAQs re Pfizer's recent policy change re CME support
7/02/08	Pfizer announces policy change re CME support

How Grant Decisions are Made

A number of factors come into play in making grant decisions. We have begun to review all grants competitively to more closely align resource availability with the highest quality grants. That review takes into account factors like use of multiple interventions and innovation in educational design. Furthermore, grant requests that propose to employ methods designed to enhance the competence and performance of healthcare providers and that reflect current research on adult learning and change will garner a higher score in review.

To illustrate further, the grant review process takes into account the following factors:

• Alignment with one of Pfizer's clinical areas of interest
• Qualifications/experience of accredited provider and educational partners
• Needs assessment that outlines gap(s) in health care performance that intervention intends to address
• Measurable educational objectives designed to change competence, performance or patient outcomes
• Educational design that incorporates multiple methods, and is based on adult learning principles
• Outcomes plan which will gather data to analyze changes in knowledge, competence or performance of target audience and aims for higher level of outcomes measurement than acquisition of knowledge/skills
• Quality-cost effectiveness and innovation demonstrated
• Degree of sustainability and access via the public domain after funding ends
• Compliance with all applicable policies and regulations